Effectiveness of lenalidomide as a topical ointment in mouse models of imiquimod-induced psoriasis
Keywords:
lenalidomide, immunomodulatory, Anti-inflammatory, baker's scoring system, imiquimod-induced psoriasis in miceAbstract
Background: Psoriasis is an inflammatory skin disorder whose cause is unknown. Psoriasis appears to be an immune-mediated disease, according to growing evidence. The immunomodulatory effects of lenalidomide inhibit the production of pro-inflammatory cytokines that have been associated with several hematologic cancers. Lenalidomide enhances the host's immune system by regulating T cell proliferation, which causes alterations in inflammation that are associated with the etiology of psoriasis. The purpose of the study: In this trial, the aim was to study the effectiveness of lenalidomide as an ointment in the treatment of psoriasis-induced in mice and to examine the histological differences between the tested groups. Materials and methods: This study was conducted from November 2021 to June 2022. 70 healthy male albino mice, which were randomly divided into seven groups of 10 mice each. Psoriasis was induced by imiquimod in groups (1, 2, 3, 4, 5 and 6). Group 1 received only 5% imiquimod cream, Group 2 received Clobetasol ointment, Group 3 received only the base containing lenalidomide and Groups (4, 5, and 6) received lenalidomide ointment (1%, 2% and 3%, respectively).
Downloads
References
Al-Bidri KZ, Salman HA, Al-Hassan Y, Hasan MS. Fibromyalgia Syndrome in a sample of Iraqi patients with psoriasis. Journal of the Faculty of Medicine Baghdad. 2014 ;56(1):49-52.
Allugunti V.R (2022). A machine learning model for skin disease classification using
Alzobaidy MA, Alburghaif AH, Alhasany HA, Naji MA. Angiotensin-Converting Enzyme Inhibitors May Increase Risk of Severe COVID-19 Infection. Annals of the Romanian Society for Cell Biology. 2021;25(6):17843–9.
Al-Zobaidy MJ, Martin W. The ability of asymmetric dimethylarginine (ADMA) or monomethylarginine (L-NMMA) to block endothelium-dependent, nitric oxide-mediated relaxation in rat aorta is inversely related to the efficacy of the relaxant stimulus. Eur J Pharmacol. 2014;741:171–7.
Araújo FA, Kelmann RG, Araújo BV, Finatto RB, Teixeira HF, Koester LS. Development and characterization of parenteral nanoemulsions containing thalidomide. European Journal of Pharmaceutical Sciences. 2011 Feb 14;42(3):238-45.
Arrieta J, Cartwright JH, Gouillart E, Piro N, Piro O, Tuval I. Geometric mixing. Philosophical Transactions of the Royal Society A. 2020 Sep 4;378(2179):20200168.
Bangun, H., Arianto, A. and Rehngenana, E. (2021) ‘Anti-ulcer Effect of Gastroretentive Drug Delivery System of Alginate Beads Containing Turmeric Extract Solid Dispersion’, Open Access Macedonian Journal of Medical Sciences, 9(A), pp. 19–27.
Cha IY, Yoo SJ, Jang JH. Recent progress in nanoparticle synthesis via liquid medium sputtering and its applications. Journal of Electrochemical Science and Technology. 2016 Mar 31;7(1):13-26.
Chanana, M. (2018). Empirical study: relationship between self efficacy and academic performance. International Journal of Health & Medical Sciences, 1(1), 28-34. https://doi.org/10.31295/ijhms.v1n1.36
Chasset F, Francès C. Current concepts and future approaches in the treatment of cutaneous lupus erythematosus: a comprehensive review. Drugs. 2019 Jul;79(11):1199-215.
Chen L, Flies DB. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nature reviews immunology. 2013 Apr;13(4):227-42.
a. convolution neural network. International Journal of Computing, Programming and Database Management 3(1), 141-147
Dellacherie MO, Seo BR, Mooney DJ. Macroscale biomaterials strategies for local immunomodulation. Nature Reviews Materials. 2019 Jun;4(6):379-97.
D'Souza C, Prince HM, Neeson PJ. Understanding the role of T-cells in the antimyeloma effect of immunomodulatory drugs. Frontiers in Immunology. 2021 Mar 5;12:632399.
Hafidh RR, Hussein SZ, Malallah MQ, Abdulamir AS. Abu Bakar F. A high-throughput quantitative expression analysis of cancer-related genes in human HepG2 cells in response to limonene, a potential anticancer agent. Current cancer drug targets. 2018;18:807–15.
Horváth S, Komlódi R, Perkecz A, Pintér E, Gyulai R, Kemény Á. Methodological refinement of Aldara-induced psoriasiform dermatitis model in mice. Scientific reports. 2019 Mar 6;9(1):1-8.
Hunt DW, Ivanova IA, Dagnino L. DRM02, a novel phosphodiesterase-4 inhibitor with cutaneous anti-inflammatory activity. Tissue barriers. 2020 Jul 2;8(3):1765633.
Hussein ZA, Shaker NS, Tahseen NJ, Al-Tuhafi AM, Mutee AF. Possible anti-psoriasis effect of the methanol extract of Phoenix dactylifera L. seeds. Journal of Herbmed Pharmacology. 2020 Jul 1;9(4):382-90.
Irrera N, Bitto A, Vaccaro M, Mannino F, Squadrito V, Pallio G, Arcoraci V, Minutoli L, Ieni A, Lentini M, Altavilla D. PDRN, a bioactive natural compound, ameliorates imiquimod-induced psoriasis through NF-κB pathway inhibition and Wnt/β-Catenin signaling modulation. International Journal of Molecular Sciences. 2020 Feb 12;21(4):1215.
Karim LM, Al-Ani NA, Abbas MH. Psoriasis Treatment by Using Narrowband-UVB Phototherapy. Iraqi Journal of Physics. 2022 ;20(1):57-62.
Khazem RM, Ibraheem SR. Detection of Some Immunological Parameters in Psoriatic Iraqi Female Patients. Iraqi Journal of Science. 2020:2515-24.
Klapper W, Klein U, De Silva NS, Zha S, Crowe JL, Dai B, Weilemann A, Okosun J, Fitzgibbon J, Du MQ, Dominguez-Sola D. Malignant Lymphomas: Biology and Molecular Pathogenesis. Walter de Gruyter GmbH & Co KG; 2016 Feb 22.
Kumar, S. (2022). A quest for sustainium (sustainability Premium): review of sustainable bonds. Academy of Accounting and Financial Studies Journal, Vol. 26, no.2, pp. 1-18
Kwaśniak K, Czarnik-Kwaśniak J, Maziarz A, Aebisher D, Zielińska K, Karczmarek-Borowska B, Tabarkiewicz J. Scientific reports concerning the impact of interleukin 4, interleukin 10 and transforming growth factor β on cancer cells. Central-European Journal of Immunology. 2019;44(2):190.
LEVIN EC, SAKO EY, FAMENINI S, WU JJ. SECTiON Vi Special Considerations. Mild to Moderate and Moderate to Severe Psoriasis (Set). 2019 Jun 24.
Li Y, Zhang G, Chen M, Tong M, Zhao M, Tang F, Xiao R, Wen H. Rutaecarpine inhibited imiquimod-induced psoriasis-like dermatitis via inhibiting the NF-κB and TLR7 pathways in mice. Biomedicine & Pharmacotherapy. 2019 Jan 1;109:1876-83.
Liu T, Zhang L, Joo D, Sun SC. NF-κB signaling in inflammation. Signal transduction and targeted therapy. 2017 Jul 14;2(1):1-9.
Lopalco G, Rigante D, Lopalco A, Emmi G, Venerito V, Vitale A, Capozio G, Denora N, Cantarini L, Iannone F. Safety of systemic treatments for Behçet’s syndrome. Expert Opinion on Drug Safety. 2020 Oct 2;19(10):1269-301.
Nedoszytko B, Sokołowska-Wojdyło M, Ruckemann-Dziurdzińska K, Roszkiewicz J, Nowicki RJ. Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: atopic dermatitis, psoriasis and skin mastocytosis. Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii. 2014 May;31(2):84.
Obeed RK, Salman HA. Treatment of Chronic Plaque Psoriasis with Etanercept and Methotrexate. Iraq Medical Journal. 2020 26;4(4).
Ogawa E, Sato Y, Minagawa A, Okuyama R. Pathogenesis of psoriasis and development of treatment. The Journal of dermatology. 2018 Mar;45(3):264-72.
Owen JA, Punt J, Stranford SA. Kuby immunology. New York: WH Freeman; 2013 Jan 25.
Paudwal G, Rawat N, Gupta R, Baldi A, Singh G, Gupta PN. Recent advances in solid dispersion technology for efficient delivery of poorly water-soluble drugs. Current Pharmaceutical Design. 2019 Apr 1;25(13):1524-35.
SAS.2010.SAS/STAT Users Guide for Personal Computer. Release 9.13.SAS Institute, Inc., Cary, N.C., USA.
Shortt J, Hsu AK, Johnstone RW. Thalidomide-analogue biology: immunological, molecular and epigenetic targets in cancer therapy. Oncogene. 2013 Sep;32(36):4191-202.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). The COVID-19 pandemic. International Journal of Health Sciences, 5(2), vi-ix. https://doi.org/10.53730/ijhs.v5n2.2937
Tageja N. Lenalidomide-current understanding of mechanistic properties. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents). 2011 Mar 1;11(3):315-26.
Thokchom SK, Gulati K, Thakur T, Rai N, Ray A. Dendritic Cells and Immunomodulation: Role in Health and Disease. Current Immunology Reviews. 2017 Aug 1;13(2):132-43.
Vo MC, Anh-NguyenThi T, Lee HJ, Nguyen-Pham TN, Lakshmi TJ, Jung SH, Kim HJ, Lee JJ. Lenalidomide enhances the function of dendritic cells generated from patients with multiple myeloma. Experimental Hematology. 2017 Feb 1;46:48-55.
Wang J, Xiang M. Targeting Potassium Channels K v1. 3 and KC a3. 1: Routes to Selective Immunomodulators in Autoimmune Disorder Treatment?. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2013 May;33(5):515-28.
Zalzala HH, Abdullah GA, Abbas MY, Mohammedsalih HR, Mahdi BM. Relationship between human leukocyte antigen DRB1 and psoriasis in Iraqi patients. Saudi Med J. 2018;39(9):886–90.
Zhang KX, D’Souza S, Upton BA, Kernodle S, Vemaraju S, Nayak G, Gaitonde KD, Holt AL, Linne CD, Smith AN, Petts NT. Violet-light suppression of thermogenesis by opsin 5 hypothalamic neurons. Nature. 2020 Sep;585(7825):420-5.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
